Department of Clinical Microbiology, Christian Medical College, Vellore 632 004, Tamil Nadu, India.
Department of Clinical Microbiology, Christian Medical College, Vellore 632 004, Tamil Nadu, India.
J Glob Antimicrob Resist. 2021 Jun;25:331-336. doi: 10.1016/j.jgar.2021.04.005. Epub 2021 May 4.
Linezolid resistance in Enterococcus faecium is emerging worldwide. In this study, we aimed to characterise two linezolid-resistant E. faecium isolates using whole-genome sequencing.
Antimicrobial susceptibility testing was performed by the broth microdilution method. A hybrid assembly approach of IonTorrent and MinION sequencing reads was used to generate the complete genome of linezolid-resistant E. faecium isolates VB3025 and VB3240.
VB3025 and VB3240 had minimum inhibitory concentration (MICs) for linezolid of 1024 μg/mL and 512 μg/mL, respectively. In addition, VB3025 was found to be resistant to both vancomycin and teicoplanin, while VB3240 was susceptible to these antibiotics. A hybrid assembly approach was used to generate the complete genome of VB3025 and VB3240 isolates harbouring the optrA gene. Notably, VB3025 carried two copies of optrA (chromosomal and plasmid), while in VB3240 optrA was identified on the chromosome. Interestingly, the plasmid pVB3025_2 co-carried the resistance gene clusters aph(3)-IIIa-sat4-ant(6)-Ia-ermB, the vanHAX operon and a copy of the optrA gene. Moreover, the optrA gene inserted into a Tn554 transposon carrying the ermA gene was identified in both VB3025 and VB3240 isolates. Furthermore, mutation analysis revealed the presence of a G2592T mutation in the 23S rRNA of both isolates.
This is the first study reporting optrA-positive linezolid-resistant E. faecium from India. A novel plasmid co-carrying vancomycin and linezolid resistance determinants highlights the threat for potential dissemination.
屎肠球菌对利奈唑胺的耐药性正在全球范围内出现。本研究旨在通过全基因组测序对两株利奈唑胺耐药屎肠球菌分离株进行特征描述。
采用肉汤微量稀释法进行抗菌药物敏感性试验。采用 IonTorrent 和 MinION 测序reads 的混合组装方法,生成利奈唑胺耐药屎肠球菌分离株 VB3025 和 VB3240 的全基因组。
VB3025 和 VB3240 的利奈唑胺最小抑菌浓度(MIC)分别为 1024 μg/mL 和 512 μg/mL。此外,VB3025 对万古霉素和替考拉宁均耐药,而 VB3240 对这些抗生素敏感。采用混合组装方法生成了携带 optrA 基因的 VB3025 和 VB3240 分离株的全基因组。值得注意的是,VB3025 携带两个 optrA 拷贝(染色体和质粒),而 VB3240 中的 optrA 基因位于染色体上。有趣的是,质粒 pVB3025_2 同时携带了耐药基因簇 aph(3)-IIIa-sat4-ant(6)-Ia-ermB、vanHAX 操纵子和一个 optrA 基因拷贝。此外,在 VB3025 和 VB3240 分离株中均发现 optrA 基因插入携带 ermA 基因的 Tn554 转座子。此外,突变分析显示,两株菌的 23S rRNA 均存在 G2592T 突变。
这是首次在印度报道 optrA 阳性的利奈唑胺耐药屎肠球菌。一种新型质粒同时携带万古霉素和利奈唑胺耐药决定簇,突显了其潜在传播的威胁。